Concepedia

M. Goldston

MG

Statistics

Publications

4

Citations

346

H-Index

4

Active since

2004

Affiliations

Ariadne Diagnostics (United States)(Current)

M. Goldston is an author at Ariadne Diagnostics (United States) specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

2004–2008

4

Publications

4

Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies

Monica Mita, Alain C. Mita, Quincy S. Chu et al. · Journal of Clinical Oncology · 2008 · 272 citations · Full text

Medicine, Oncology, Pharmacology +10

Phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of AP23573, an mTOR Inhibitor, administered IV daily X 5 every other week in patients (pts) with refractory or advanced malignancies

Monica Mita, Eric K. Rowinsky, M. Goldston et al. · Journal of Clinical Oncology · 2004 · 41 citations

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacodynamic study of skin biopsy specimens in patients (pts) with refractory or advanced malignancies following administration of AP23573, an mTOR inhibitor

Victor M. Rivera, Jeffrey I. Kreisberg, Monica Mita et al. · Journal of Clinical Oncology · 2005 · 18 citations

Medicine, Oncology, Pharmacology +17

Durable disease stabilization and antitumor activity with OSI-774 in renal cell carcinoma: A phase II, pharmacokinetic (PK) and biological correlative study with FDG-PET imaging

Muralidhar Beeram, Eric K. Rowinsky, Geoffrey R. Weiss et al. · Journal of Clinical Oncology · 2004 · 15 citations

Medicine, Nuclear Medicine, Oncology +5

1–4 of 4